Reza Shahsiah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Reza Shahsiah has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Farid Azmoudeh Ardalan
Pathology and Laboratory Medicine Department, Imam Khomeini Hospital Complex Tehran University of Medical Sciences Tehran Iran
4 shared publications Jenefer DeKoning
Kashi Clinical Laboratories, USA
2 shared publicationsSaeed Samie
Pars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, Iran
2 shared publicationsSeyed Ziaeddin Latifzadeh
Pars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, Iran
2 shared publicationsZahra Mehdizadeh Kashi
Kashi Clinical Laboratories, USA
2 shared publications- Abdolmajid Zarei
Department of Pathology and Laboratory Medicine, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- 1 December 2017
- Published by Elsevier in Pathology - Research and Practice
- Vol. 213 (12) , 1576
Corrigendum to “Validation of a next generation sequencing panel for detection of hotspot cancer mutations in a clinical laboratory” [Journal information: Pathology-Research and Practice, 2017, Volume 213, Issue 2, Pages: 98-105]
- 1 December 2017
- Published by Elsevier in Pathology - Research and Practice
- Vol. 213 (12) , 1576
Corrigendum to “Validation of a next generation sequencing panel for detection of hotspot cancer mutations in a clinical laboratory” [Journal information: Pathology-Research and Practice, 2017, Volume 213, Issue 2, Pages: 98-105]
- 1 February 2017
- Published by Elsevier in Pathology - Research and Practice
- Vol. 213 (2) , 98-105
Validation of a next generation sequencing panel for detection of hotspot cancer mutations in a clinical laboratory
- 1 February 2017
- Published by Elsevier in Pathology - Research and Practice
- Vol. 213 (2) , 98-105
Validation of a next generation sequencing panel for detection of hotspot cancer mutations in a clinical laboratory
- 1 January 2014
- Vol. 52 (3) , 197-200
Human papilloma virus and esophageal squamous cell carcinoma.
Human papillomavirus (HPV) has also been suggested as an etiology of esophageal squamous cell carcinoma (SCC). The aim of this study was to investigate the prevalence of HPV infection in esophageal SCCs in our region with strict contamination control to prevent false positive results. Thirty cases of esophageal squamous cell carcinomas were chosen by simple random selection in a period of two years. PCR for target sequence of HPV L1 gene was performed on nucleic acid extracted from samples by means of GP5+/GP6+ primers. All tissue samples in both case and control groups were negative for HPV-DNA. Although the number of cases in this study was limited, the contribution of HPV in the substantial number of esophageal SCCs in our region is unlikely.
- 1 January 2014
- Vol. 52 (3) , 197-200
Human papilloma virus and esophageal squamous cell carcinoma.
Human papillomavirus (HPV) has also been suggested as an etiology of esophageal squamous cell carcinoma (SCC). The aim of this study was to investigate the prevalence of HPV infection in esophageal SCCs in our region with strict contamination control to prevent false positive results. Thirty cases of esophageal squamous cell carcinomas were chosen by simple random selection in a period of two years. PCR for target sequence of HPV L1 gene was performed on nucleic acid extracted from samples by means of GP5+/GP6+ primers. All tissue samples in both case and control groups were negative for HPV-DNA. Although the number of cases in this study was limited, the contribution of HPV in the substantial number of esophageal SCCs in our region is unlikely.
- 30 November 2013
- Published by Elsevier in Journal of Virological Methods
- Vol. 193 (2) , 683-686
Application of quality control planning methods for the improvement of a quantitative molecular assay
- 30 November 2013
- Published by Elsevier in Journal of Virological Methods
- Vol. 193 (2) , 683-686
Application of quality control planning methods for the improvement of a quantitative molecular assay
- 1 December 2011
- Published by Elsevier in Pathology - Research and Practice
- Vol. 207 (12) , 754-757
Human papillomavirus genotypes in Iranian patients with cervical cancer
- 1 December 2011
- Published by Elsevier in Pathology - Research and Practice
- Vol. 207 (12) , 754-757
Human papillomavirus genotypes in Iranian patients with cervical cancer
- 12 July 2011
- Published by BMJ in Journal of Clinical Pathology
- Vol. 64 (11) , 973-976
Malignant ovarian germ cell tumours in gonadal Y chromosome mosaicism
Aims Previous studies have shown that two partially overlapping mechanisms are responsible for the development of malignant ovarian germ cell tumours (MOGCT): either spontaneous mutations, mostly in KIT gene, or the presence of Y chromosome material, in dysgenetic gonads. While unilateral oophorectomy and preservation of fertility is favourable in most cases, presence of whole or part of Y chromosome in dysgenetic ovaries is associated with a risk of bilateral germ cell tumour development. The aim of this study was to evaluate the frequency of Y chromosome material in these tumours. Methods A total of 47 cases with histopathologic diagnosis of malignant germ cell tumour were selected in a period of 9 years. A relative quantitative PCR (RQ-PCR) method was designed and validated to detect testis-specific protein Y-encoded (TSPY) gene on Y chromosome. After DNA extraction, TSPY gene was sought as a surrogate of Y chromosome. Results Significant amounts of TSPY gene were found in seven cases, two of which had gonadoblastoma and one had cytogenetic proof of Y chromosome presence. Conclusions Some MOGCTs develop on the background of gonadal mosaicism and gonadal dysgenesis. Bilateral oophorectomy may be indicated in patients with these disorders because they are at risk of developing an MOGCT on the contralateral gonad. Moreover, this chromosomal abnormality is hardly found by routine methods, and the abnormality is more easily sought in MOGCT cells by means of RQ-PCR.
- 12 July 2011
- Published by BMJ in Journal of Clinical Pathology
- Vol. 64 (11) , 973-976
Malignant ovarian germ cell tumours in gonadal Y chromosome mosaicism
Aims Previous studies have shown that two partially overlapping mechanisms are responsible for the development of malignant ovarian germ cell tumours (MOGCT): either spontaneous mutations, mostly in KIT gene, or the presence of Y chromosome material, in dysgenetic gonads. While unilateral oophorectomy and preservation of fertility is favourable in most cases, presence of whole or part of Y chromosome in dysgenetic ovaries is associated with a risk of bilateral germ cell tumour development. The aim of this study was to evaluate the frequency of Y chromosome material in these tumours. Methods A total of 47 cases with histopathologic diagnosis of malignant germ cell tumour were selected in a period of 9 years. A relative quantitative PCR (RQ-PCR) method was designed and validated to detect testis-specific protein Y-encoded (TSPY) gene on Y chromosome. After DNA extraction, TSPY gene was sought as a surrogate of Y chromosome. Results Significant amounts of TSPY gene were found in seven cases, two of which had gonadoblastoma and one had cytogenetic proof of Y chromosome presence. Conclusions Some MOGCTs develop on the background of gonadal mosaicism and gonadal dysgenesis. Bilateral oophorectomy may be indicated in patients with these disorders because they are at risk of developing an MOGCT on the contralateral gonad. Moreover, this chromosomal abnormality is hardly found by routine methods, and the abnormality is more easily sought in MOGCT cells by means of RQ-PCR.
- 3 February 2011
- Vol. 48 (5) , 279-82
Result variation and efficiency kinetics in real-time PCR.
Fluorescent monitoring of DNA amplification is the basis of real-time PCR. Absolute quantification can be achieved using a standard curve method. The standard curve is constructed by amplifying known amounts of standards under identical conditions to that of the samples.The objective of the current study is to propose a mathematical model to assess the acceptability of PCR results. Four commercial standards for HCV-RNA (hepatitis C virus RNA) along with 6 patient samples were measured by real-time PCR, using two different RT-PCR reagents. The standard deviation of regression (Sy,x) was calculated for each group of standard and compared by F-Test. The efficiency kinetics was computed by logistic regression, c2 goodness of fit test was preformed to assess the appropriateness of the efficiency curves.Calculated efficiencies were not significantly different from the value predicted by logistic regression model. Reactions with more variation showed less stable efficiency curves, with wider range of amplification efficiencies.Amplification efficiency kinetics can be computed by fitting a logistic regression curve to the gathered fluorescent data of each reaction. This model can be employed to assess the acceptability of PCR results calculated by standard curve method.
- 3 February 2011
- Vol. 48 (5) , 279-82
Result variation and efficiency kinetics in real-time PCR.
Fluorescent monitoring of DNA amplification is the basis of real-time PCR. Absolute quantification can be achieved using a standard curve method. The standard curve is constructed by amplifying known amounts of standards under identical conditions to that of the samples.The objective of the current study is to propose a mathematical model to assess the acceptability of PCR results. Four commercial standards for HCV-RNA (hepatitis C virus RNA) along with 6 patient samples were measured by real-time PCR, using two different RT-PCR reagents. The standard deviation of regression (Sy,x) was calculated for each group of standard and compared by F-Test. The efficiency kinetics was computed by logistic regression, c2 goodness of fit test was preformed to assess the appropriateness of the efficiency curves.Calculated efficiencies were not significantly different from the value predicted by logistic regression model. Reactions with more variation showed less stable efficiency curves, with wider range of amplification efficiencies.Amplification efficiency kinetics can be computed by fitting a logistic regression curve to the gathered fluorescent data of each reaction. This model can be employed to assess the acceptability of PCR results calculated by standard curve method.
- Open Access
- 1 January 2008
- Published by Springer Nature in Diagnostic Pathology
- Vol. 3 (1) , 19
Detection of Epstein Barr Virus by Chromogenic In Situ Hybridization in cases of extra-hepatic biliary atresia
Extra-hepatic biliary atresia (EHBA) is an important cause of neonatal cholestasis. Several infectious agents have been proposed as etiologic factors such as Rotavirus and Reovirus. There is limited data on the role of Epstein Barr virus (EBV) infection in EHBA, so we decided to study the presence of EBV virus in a series of 16 proven EHBA cases by Chromogenic in situ hybridization (CISH) technique.
- 1 January 2008
- Published by Springer Nature in Diagnostic Pathology
- Vol. 3 (1) , 19
Open AccessDetection of Epstein Barr Virus by Chromogenic In Situ Hybridization in cases of extra-hepatic biliary atresia
Extra-hepatic biliary atresia (EHBA) is an important cause of neonatal cholestasis. Several infectious agents have been proposed as etiologic factors such as Rotavirus and Reovirus. There is limited data on the role of Epstein Barr virus (EBV) infection in EHBA, so we decided to study the presence of EBV virus in a series of 16 proven EHBA cases by Chromogenic in situ hybridization (CISH) technique.